Cognitive and Hormonal Treatment of Sex Offenders

Paraphilia Clinical Trial

Official title:

Cognitive Group and Hormonal Treatment of Sex Offenders.

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00379626
• Other study ID #: AH 048-01
• Status: Terminated
• Phase: Phase 1
• First received: September 21, 2006
• Last updated: February 13, 2017
• Start date: August 2003
• Est. completion date: August 2010

Study information

• Verified date: February 2017
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to determine if Cognitive treatment and hormone treatment can change the relapse rate of sexual offenders.

Description:

The aim of this study is to determine if Cognitive treatment and hormone treatment can change the relapse rate of sexual offenders.

In the first part of study we are studying changes in the offenders cognitive distortions and in the second part we are studying changes in sexual activities and sexual thoughts after treatment with Leuprorelin. The study is an open pre and post study.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 5
• Est. completion date: August 2010
• Est. primary completion date: August 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

Men sentenced for paraphilia

Exclusion Criteria:

Men above 70 years and men that does not speak english

Related Conditions & MeSH terms

• Paraphilia

Intervention

Drug:
• cognitive and hormone treatment
cognitive and hormone (Leuprorelin) treatment

Locations

Country	Name	City	State
Norway	St. Olavs Hospital. Departement for forensic psyciatry, Brøset.	Trondheim

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Nøttestad JA, Bjarnar E, Lundmo PI, Sandvik M. [Treatment of sex offenders with leuprorelin]. Tidsskr Nor Laegeforen. 2006 Feb 23;126(5):633-4. Norwegian. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The degree of cognitive distortions after treatment		8 months
Secondary	Locus of control after treatment in part one.		8 months
Secondary	Degree of mental health problems (SCL-90)		8 months
Secondary	The testosterone levels before, during and after treatment	measured each 3rd month	baseline upto 8 months